M&T Bank
NUVB icon

M&T Bank’s Nuvation Bio NUVB Stock Holding History

M&T Bank’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$97.6K Sell
22,758
-820
-3% -$4.57K ﹤0.01% 1631
2025
Q4 		$211K Buy
+23,578
New +$146K ﹤0.01% 1548

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

M&T Bank's NUVB Position: Q1 2026 in Review

M&T Bank reduced its Nuvation Bio (NUVB) stake by 3.5% in Q1 2026, selling an estimated $4.57K and leaving 22,758 shares worth $97.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1631.

M&T Bank first reported a position in NUVB in Q4 2025 and has held it in 2 quarters since. The position peaked at $211K in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • M&T Bank held 22,758 shares of Nuvation Bio worth $97.6K as of Q1 2026.
  • M&T Bank sold 820 Nuvation Bio shares in Q1 2026, an estimated $4.57K.
  • Nuvation Bio made up ﹤0.01% of M&T Bank's portfolio in Q1 2026, its #1631 holding.
  • M&T Bank first reported a position in Nuvation Bio in Q4 2025 and has held it in 2 quarters since.
  • M&T Bank's Nuvation Bio position peaked at $211K in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.